![David R. Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David R. Liu
Keine laufenden Positionen mehr
Karriereverlauf von David R. Liu
Ehemalige bekannte Positionen von David R. Liu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TERNS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | - | - |
Chroma Medicine, Inc.
![]() Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Gründer | 01.01.2020 | - |
BEAM THERAPEUTICS INC. | Gründer | 25.01.2017 | - |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Founder | 2 |
Director/Board Member | 1 |
Sektoral
Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BEAM THERAPEUTICS INC. | Health Technology |
TERNS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Chroma Medicine, Inc.
![]() Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Health Technology |
- Börse
- Insiders
- David R. Liu
- Erfahrung